The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era
Frontiers in oncology
; 12, 2022.
Article
in English
| EuropePMC | ID: covidwho-2045999
ABSTRACT
The uncontrollable COVID-19 crises in the SARS-CoV-2 high-prevalence areas have greatly disrupted the routine treatment of liver cancer and triggered a role transformation of radiotherapy for liver cancer. The weight of radiotherapy in the treatment algorithm for liver cancer has been enlarged by the COVID-19 pandemic, which is helpful for the optimal risk-benefit profile.
Search on Google
Collection:
Databases of international organizations
Database:
EuropePMC
Language:
English
Journal:
Frontiers in oncology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS